A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Clinical Efficacy of Two Different Doses of F8IL10 (Dekavil) Administered Subcutaneously to Patients With Active Rheumatoid Arthritis Receiving Methotrexate.
Sponsor: Philogen S.p.A.
Terminated
Approvals of new agents for the same indication have significantly slowed down the recruitment in this trial making the prosecution of the present investigation extremely difficult.
Other terminated trials from Philogen S.p.A.
- Diffuse Large B-cell Lymphoma (DLBCL) · Phase PHASE1/PHASE2 · Sep 2023
- Acute Myeloid Leukemia, Relapsed, Adult · Phase PHASE1 · Sep 2023
- Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection · Phase PHASE1 · Nov 2014
- Advanced Solid Tumor · Phase PHASE1/PHASE2 · Dec 2012
- Non Small Cell Lung Cancer · Phase PHASE1 · Oct 2012
More terminations from Philogen S.p.A.
Other Rheumatoid Arthritis trials with similar outcome
A PHASE2 clinical study on Rheumatoid Arthritis, this trial is terminated or withdrawn. The trial is conducted by Philogen S.p.A. and has accumulated 10 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jul 2023 — Jul 2024 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
May 2023 — Jul 2023 [monthly]
Active Not Recruiting PHASE2
▶ Show 5 earlier versions
-
May 2022 — May 2023 [monthly]
Active Not Recruiting PHASE2
Status: Unknown Status → Active Not Recruiting
-
Jan 2021 — May 2022 [monthly]
Unknown Status PHASE2
-
Nov 2018 — Jan 2021 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Philogen S.p.A.
For direct contact, visit the study record on ClinicalTrials.gov .